RESÚMENES JULIO 2009

.

Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

3 - Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

Bradley Ng and Angela O’Brien

Advances in Psychiatric Treatment (2009) 15: 297-305

 

GRATIS 3! - The Sedating Antidepressant Trazodone Impairs Sleep-Dependent Cortical Plasticity

Sara J. Aton, Julie Seibt, Michelle C. Dumoulin, Tammi Coleman, Mia Shiraishi, Marcos G. Frank

PLoS ONE 4(7): e6078

 

3! - Why are Guidelines More Irrational than Metaanalyses?

Tilman  Steinert

Psychiat Prax 2009; 36: 238-242

 

3 - Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition

S. Bálint, P. Czobor, S. Komlósi, Á. Mészáros, V. Simon and I. Bitter

Psychological Medicine (2009), 39:1337-1345

 

3! - Mental disorders, comorbidity and suicidal behavior: Results from the National Comorbidity Survey Replication

M K Nock, I Hwang, N A Sampson and R C Kessler

Molecular Psychiatry advance online publication 31 March 2009

 

3! - The use of atypical antipsychotics in dementia: rethinking Simpson's paradox

Guk-Hee Suh

International Psychogeriatrics (2009), 21:616-621

 

3! - Prevalence of dementia in Latin America: a collaborative study of population-based cohorts

Ricardo Nitrini, Cássio M. C. Bottino, Cecilia Albala, Nilton Santos Custodio Capuñay, Carlos Ketzoian, Juan J. Llibre Rodriguez, Gladys E. Maestre, Ana Teresa A. Ramos-Cerqueira and Paulo Caramelli

International Psychogeriatrics (2009), 21:622-630

 

3 - Sleep disturbances in older adults with mild cognitive impairment

Simon Beaulieu-Bonneau and Carol Hudon

International Psychogeriatrics (2009), 21:654-666

 

3 - Bright light therapy for agitation in dementia: a randomized controlled trial

Alistair Burns, Harry Allen, Barbara Tomenson, Debbie Duignan and Jane Byrne

International Psychogeriatrics (2009), 21:711-721

 

3 - Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania

R. Chandrasena , D. Dvořáková , S. I. Lee , N. Loza, S. N. Mosolov, P. Osváth, P. Pregelj, R. J. Walton, J. Karagianis, T. Treuer

International Journal of Clinical Practice. Volume 63 Issue 8, Pages 1249 - 1258

 

3! - Neuroprotective Effects of Statins in an In Vitro Model of Alzheimer's Disease

Ana Catarina R.G. Fonseca, Teresa Proença, Rosa Resende, Catarina R. Oliveira, Cláudia M.F. Pereira

Journal of Alzheimer's Disease. Volume 17, Number 3 / 2009: 503-517

 

3! - Predictive Value of Family History on Severity of Illness. The Case for Depression, Anxiety, Alcohol Dependence, and Drug Dependence

Barry J. Milne, Avshalom Caspi, HonaLee Harrington, Richie Poulton, Michael Rutter, Terrie E. Moffitt

Arch Gen Psychiatry. 2009;66(7):738-747

 

5 - N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania. A Double-blind, Placebo-Controlled Study

Jon E. Grant, Brian L. Odlaug, Suck Won Kim

Arch Gen Psychiatry. 2009;66(7):756-763

 

3! - Cross-National Associations Between Gender and Mental Disorders in the World Health Organization World Mental Health Surveys

Soraya Seedat, Kate Margaret Scott, Matthias C. Angermeyer, Patricia Berglund, Evelyn J. Bromet, Traolach S. Brugha, Koen Demyttenaere, Giovanni de Girolamo, Josep Maria Haro, Robert Jin, Elie G. Karam, Viviane Kovess-Masfety, Daphna Levinson, Maria Elena Medina Mora, Yutaka Ono, Johan Ormel, Beth-Ellen Pennell, Jose Posada-Villa, Nancy A. Sampson, David Williams, Ronald C. Kessler

Arch Gen Psychiatry. 2009;66(7):785-795

 

3 - Neuropsychological Differential Diagnosis of Degenerative Dementias

S. A. Wolf

Fortschr Neurol Psychiatr 2009; 77: 376-388

 

3 - Depressive Disorders in Dementia and Mild Cognitive Impairments: Is Comorbidity a Cause or a Risk Factor?

U. W. Preuss, N. Siafarikas, M. Petrucci, W. M. Wong

Fortschr Neurol Psychiatr 2009; 77: 399-406

 

3 - Sensitivity of Neurochemical Dementia Diagnostics in CSF Compared to 99mTc-SPECT in Alzheimer's Dementia

M. Weih, M. Krinninger, R. Zimmermann, P. Lewczuk, J. Svitek, G. Schaller, Ü. Degirmenci, T. Richter-Schmidinger, J. Wiltfang, T. Kuwert, J. Kornhuber, D. Schmidt

Fortschr Neurol Psychiatr 2009; 77: 407-411

 

GRATIS 3 - New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

Rüdiger Hardeland

Neuropsychiatric Disease and Treatment, June 2009

 

3 - Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US: An Analysis of National Survey Data

Kamble, Pravin; Chen, Hua; Sherer, Jeffrey T; Aparasu, Rajender R

Drugs & Aging. 26(6):483-492, June 6, 2009


3! - Prenatal Stress and Cerebral Palsy: A Nationwide Cohort Study in Denmark

Jiong Li, Mogens Vestergaard, Carsten Obel, Dorthe Hansen Precht, Jakob Christensen, Michael Lu, and Jørn Olsen

Psychosomatic Medicine 71:615-618 (2009)

3 - Tobacco Smoking in Individuals with Attention-Deficit Hyperactivity Disorder: Epidemiology and Pharmacological Approaches to Cessation

Gray, Kevin M; Upadhyaya, Himanshu P

CNS Drugs. 23(8):661-668, August 8, 2009

3! - The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease

D Aarsland, K Brønnick, G Alves, O B Tysnes, K F Pedersen, U Ehrt, J P Larsen

Journal of Neurology, Neurosurgery, and Psychiatry 2009;80:928-930

 

3 - An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

Bruno P Imbimbohttp://www.informahealthcare.com/entityImage/?code=200B

Expert Opinion on Investigational Drugs. August 2009, Vol. 18, No. 8, Pages 1147-1168


3 - The epidemiology of insomnia: Associations with physical and mental health.: The HUNT-2 study

Børge Sivertsen, Steinar Krokstad, Simon Øverland and Arnstein Mykletun

Journal of Psychosomatic Research. Volume 67, Issue 2, August 2009, Pages 109-116


3 - Frequency and predictors of obstructive sleep apnea among individuals with major depressive disorder and insomnia

Jason C. Ong, Jenna L. Gress, Melanie G. San Pedro-Salcedo and Rachel Manber

Journal of Psychosomatic Research. Volume 67, Issue 2, August 2009, Pages 135-141

 

3 - A Haplotype of the Norepinephrine Transporter (Net) Gene Slc6a2 is Associated with Clinical Response to Atomoxetine in Attention-Deficit Hyperactivity Disorder (ADHD)

Nicolas Ramoz, Claudette Boni, AnnCatherine M Downing, Sandra L Close, Sandra L Peters, Angela M Prokop, Albert J Allen, Michel Hamon, Diane Purper-Ouakil and Philip Gorwood

Neuropsychopharmacology (2009) 34, 2135–2142

 

3 - Topiramate Reduces Excitability in the Basolateral Amygdala by Selectively Inhibiting GluK1 (GluR5) Kainate Receptors on Interneurons and Positively Modulating GABAA Receptors on Principal Neurons

Maria F. M. Braga, Vassiliki Aroniadou-Anderjaska, He Li, and Michael A. Rogawski

JPET 330:558-566, 2009

 

3! - The late-life dementia risk index

D. E. Barnes, K. E. Covinsky, R. A. Whitmer, L. H. Kuller, O. L. Lopez, and K. Yaffe

NEUROLOGY 2009;73:173-179

GRATIS 3 - Treatment of obese patients with binge eating disorder using topiramate: a review

Paolo Leombruni, Luca Lavagnino, Secondo Fassino

Neuropsychiatric Disease and Treatment. July 2009

 

4 - History of depressive and/or anxiety disorders as a predictor of treatment response: A post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia

Chi-Un Pae, Prakash S. Masand, David M. Marks, Stan Krulewicz, Kathleen Peindl, Paolo Mannelli and Ashwin A. Patkar

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 996-1002


3 - Zaleplon increases nocturnal melatonin secretion in humans

A.L. Morera, P. Abreu-Gonzalez and M. Henry

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 1013-1016

 

3! - CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Niklas Mattsson, Henrik Zetterberg, Oskar Hansson, Niels Andreasen, Lucilla Parnetti, Michael Jonsson, Sanna-Kaisa Herukka, Wiesje M. van der Flier, Marinus A. Blankenstein, Michael Ewers, Kenneth Rich, Elmar Kaiser, Marcel Verbeek, Magda Tsolaki, Ezra Mulugeta, Erik Rosén, Dag Aarsland, Pieter Jelle Visser, Johannes Schröder, Jan Marcusson, Mony de Leon, Harald Hampel, Philip Scheltens, Tuula Pirttilä, Anders Wallin, Maria Eriksdotter Jönhagen, Lennart Minthon, Bengt Winblad, Kaj Blennow

JAMA. 2009;302(4):385-393

 

3 - Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review
Rosa L. Drijgers, Pauline Aalten, Ania Winogrodzka, Frans R.J. Verhey, Albert F.G. Leentjens
Dement Geriatr Cogn Disord 2009;28:13-22

 

3 - Depressed Mood is Not a Risk Factor for Incident Dementia in a Community-Based Cohort

Becker, James T; Chang, Yue-Fang; Lopez, Oscar L; Dew, Mary Amanda; Sweet, Robert A; Barnes, Deborah; Yaffe, Kristine; Young, Jeffrey; Kuller, Lewis; Reynolds, Charles F. III

American Journal of Geriatric Psychiatry: August 2009 - Volume 17 - Issue 8 - pp 653-663

 

5< - Double-Blind Treatment of Apathy in Patients with Poststroke Depression Using Nefiracetam

Robert G. Robinson, Ricardo E. Jorge, Kathleen Clarence-Smith, and Sergio Starkstein

J Neuropsychiatry Clin Neurosci 21:144-151, Spring

 

3 - Delirium in the elderly: a clinical review

S Saxena, D Lawley

Postgraduate Medical Journal 2009;85:405-413

 

3! - Pharmacokinetics and dosage adjustment in patients with renal dysfunction

Roger K. Verbeeck and Flora T. Musuamba

European Journal of Clinical Pharmacology. Volume 65, Number 8 / August, 2009: 757-773

 

3! - Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population. The 3-City Study

Isabelle Carrière, Annie Fourrier-Reglat, Jean-François Dartigues, Olivier Rouaud, Florence Pasquier, Karen Ritchie, Marie-Laure Ancelin

Arch Intern Med. 2009;169(14):1317-1324

 

5 - Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial




References and further reading may be available for this article. To view references and further reading you must
purchase this article.

Amy S. Chappell, Melissa J. Ossanna, Hong Liu-Seifert, Smriti Iyengar, Vladimir Skljarevski, Linda Chunhong Li, Robert M. Bennett and Harry Collins

Pain. Article in Press, July 2009

 

2 - Investigating the Efficacy of Paroxetine in Developmental Stuttering

Busan, Pierpaolo; Battaglini, Piero Paolo; Borelli, Massimo; Evaristo, Pasquale; Monti, Fabrizio; Pelamatti, Giovanna

Clinical Neuropharmacology: July/August 2009 - Volume 32 - Issue 4 - pp 183-188

 

GRATIS 3 - Borderline Personality Disorder: Toward Integration

Dan J. Stein

CNS Spectr. 2009;14(7):352-356

 

GRATIS 2 - Nail-Biting Stuff? The Effect of N-acetyl Cysteine on Nail-Biting

Michael Berk, Sue Jeavons, Olivia M. Dean, Seetal Dodd, Kirsteen Moss, Clarissa S. Gama, and Gin S. Malhi

CNS Spectr. 2009;14(7):357-360

 

GRATIS 3 - Gender Differences in the Association Between Body Mass Index and Psychopathology

Rani A. Desai, Melinda Manley, Mayur M. Desai, and Marc N. Potenza

CNS Spectr. 2009;14(7):372-383

 

GRATIS 3 - Evidence-based Approaches to Preventing Alzheimer’s Disease: Part 2

Nazem Bassil, and George T. Grossberg

Primary Psychiatry. 2009;16(7):33-38

 

GRATIS 3 - Complementary, Alternative, and Integrative Rx:Safety Issues

James Lake

Psychiatric Times. 2009; Vol. 26 No. 7

.

Regresar a RESÚMENES JULIO 2009

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.